Azkoyen (AZK)
Madrid Stock Exchange · Spain · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 10.25 |
|---|---|
| 52-week range | 8.14 – 14.95 |
| Return, 1 month / 3 months | −0.5% / −7.7% |
| Return, 1 year / 3 years | +17.0% / +96.1% |
| Trend | Below its 200-day average |
| RSI (14) | 52 |
| Volatility (1 year) | 27.8% |
| Worst drawdown (1 year) | -31.1% |
| Average daily value traded | 0.21M EUR |
| Dividend yield | 2.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Azkoyen is a Spanish industrial company based in Navarra that designs and manufactures vending machines and payment systems. Its vending equipment serves coffee, snacks and drinks, while its payment division supplies coin mechanisms, bill validators and cash handling technology. Customers include operators of vending networks, retailers and businesses that need automated payment and dispensing equipment, mainly in Europe and other international markets.
The shares are listed on the Madrid Stock Exchange in Spain under the code AZK, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Azkoyen (AZK) trades on the Madrid Stock Exchange in Spain. It last closed at EUR 10.25 on 27 October 2026.
Its price-based Market X-Ray is 45 out of 100 (a weak price profile), ranking 151 of 236 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 17.0% and over the last three months it fell 7.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Madrid Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 34 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -1.7% | ||
| From 52-week high | -30.5% | ||
| Momentum | 53 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -7.7% | ||
| 6-month return | -0.4% | ||
| 12-month return, skipping the last month | 17.6% | ||
| Stability (higher is calmer) | 33 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 27.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -31.1% | ||
| Liquidity | 67 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.21M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 47 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.8% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | −0.5% |
| 3 months | −7.7% |
| 6 months | −0.4% |
| 1 year | +17.0% |
| 3 years | +96.1% |
| 5 years | +104.4% |
Signals
| 50-day / 200-day average | 10.13 / 10.42 |
|---|---|
| Golden / death cross (60 days) | Death, 20 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.14 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 Jul 2026 | EUR 0.2884 |
| 18 Jun 2025 | EUR 0.3110 |
| 3 Jul 2024 | EUR 0.2908 |
| 19 Jul 2023 | EUR 0.1500 |
| 14 Jul 2022 | EUR 0.1920 |
| 24 Jun 2021 | EUR 0.1620 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Madrid Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.